Patents by Inventor Tae Kwann PARK

Tae Kwann PARK has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition containing mTOR inhibitor for treating macular degeneration
    Patent number: 10583150
    Abstract: The present invention relates to a pharmaceutical composition for treating macular degeneration, and more particularly to a pharmaceutical composition for treating macular degeneration, which comprises an inhibitor of mTOR gene expression. The pharmaceutical composition according to the present invention can effectively treat age-related macular degeneration, a representative retinal disease that causes blindness in adults.
    Type: Grant
    Filed: March 17, 2017
    Date of Patent: March 10, 2020
    Assignee: CuroGene Life Sciences Co., Ltd.
    Inventors: Young-Ill Lee, Steven Hyun Seung Lee, Tae Kwann Park
  • PHARMACEUTICAL COMPOSITION CONTAINING mTOR INHIBITOR FOR TREATING MACULAR DEGENERATION
    Publication number: 20190192551
    Abstract: The present invention relates to a pharmaceutical composition for treating macular degeneration, and more particularly to a pharmaceutical composition for treating macular degeneration, which comprises an inhibitor of mTOR gene expression. The pharmaceutical composition according to the present invention can effectively treat age-related macular degeneration, a representative retinal disease that causes blindness in adults.
    Type: Application
    Filed: March 17, 2017
    Publication date: June 27, 2019
    Inventors: Young-Ill LEE, Steven Hyun Seung LEE, Tae Kwann PARK